AI drug discovery company

Anew Labs

Data as of Oct 17, 2026.

Company facts

Headquarters

China (Shanghai)

ReportedSource for headquarters (opens in new tab)

Latest funding round

Round: First external round
Date: Sep 16, 2026
Amount: $290M
Lead investor: HSG, IDG Capital and Hillhouse (5Y Capital co-led)

ReportedSource for the latest round (opens in new tab)

Recent news

Sep 23, 2026

ByteDance AI drug discovery spinoff raised $290M at $1.5B valuation

ReportedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.